Back to Search Start Over

Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells.

Authors :
Majd, Mostafa Heidari
Barar, Jaleh
Asgari, Davoud
Valizadeh, Hadi
Rashidi, Mohammad Reza
Kafil, Vala
Shahbazi, Javid
Omidi, Yadollah
Source :
Advanced Pharmaceutical Bulletin; Mar2013, Vol. 3 Issue 1, p189-195, 7p
Publication Year :
2013

Abstract

Purpose: To achieve simultaneous imaging and therapy potentials, targeted fluoromagnetic nanoparticles were synthesized and examined in human breast cancer MCF-7 cells. Methods: Fe<subscript>3</subscript>O<subscript>4</subscript> nanoparticles (NPs) were synthesized through thermal decomposition of Fe(acac)<subscript>3</subscript>. Then, magnetic nanoparticles (MNPs) modified by dopamine-poly ethylene glycol (PEG)-NH<subscript>2</subscript>; finally, half equivalent fluorescein isothiocyanate (FITC) and half equivalent folic acid were conjugated to one equivalent of it. The presence of Fe<subscript>3</subscript>O<subscript>4</subscript>-DPA-PEG-FA/FITC in the folate receptor (FR) positive MCF-7 cells was determined via fluorescent microscopy to monitor the cellular interaction of MNPs. Results: FT-IR spectra of final compound confirmed existence of fluorescein on folic acid grafted MNPs. The Fe<subscript>3</subscript>O<subscript>4</subscript>-DPA-PEG-FA/FITC NPs, which displayed a size rang about 30-35 nm using scanning electron microscopy (SEM) and transmission electron microscopy (TEM), were able to actively recognize the FR-positive MCF-7 cells, but not the FR-negative A549 cells. Conclusion: The uniform nano-sized Fe<subscript>3</subscript>O<subscript>4</subscript>-DPA-PEG-FA/FITC NPs displayed great potential as theranostics and can be used for targeted imaging of various tumors that overexpress FR. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22285881
Volume :
3
Issue :
1
Database :
Complementary Index
Journal :
Advanced Pharmaceutical Bulletin
Publication Type :
Academic Journal
Accession number :
85505390
Full Text :
https://doi.org/10.5681/apb.2013.031